Here are 10 healthcare industry lawsuits, settlements and legal developments that Becker's has reported since Sept. 13: ...

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the ...

As a possible indication that the hearing, which starts at 10a ET, could get contentious, it has the title, "Why is Novo ...

FTC Takes Action Against Pharmacies Inflating Insulin Prices (Washington, DC) -- The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices. The FCC says ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

The agency plans to argue that the company illegally penalizes customers that try to use rival payment processors.

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

Deteriorating conditions can send people to the ER with falls and injuries. And toxic pollutants contribute to health ...